Clinical Chemistry Podcast
A Nanoparticle-Lectin Immunoassay Improves Discrimination of Serum CA125 from Malignant and Benign Sources
- Autor: Vários
- Narrador: Vários
- Editor: Podcast
- Duración: 0:09:33
- Mas informaciones
Informações:
Sinopsis
Measurement of serum cancer antigen 125 (CA125) is the standard approach for epithelial ovarian cancer (EOC) diagnostics and follow-up. However, the clinical specificity is not optimal because increased values are also detected in healthy controls and in benign diseases.
